Advertisement

Conservative Treatment: Nutritional Treatment

  • Ryujin EndoEmail author
  • Yasuhiro Takikawa
Chapter

Abstract

In liver cirrhosis, the nutritional elements and the energy metabolism are disturbed, resulting in the status of protein-energy malnutrition (PEM). PEM is common in patients with liver cirrhosis and is also a significant predictor of complications and survival in these patients. On the other hand, the bleeding from esophagogastric varices is still a major and severe complication affecting the prognosis of liver cirrhosis. Although endoscopic therapy and interventional radiology therapy have been widely performed as treatments for portal hypertension, the patients often require dietary restriction after these treatments, resulting in the aggravation of PEM. It has recently become evident that late evening snack improved the status of energy malnutrition and long-term oral administration of branched-chain amino acids (BCAA) supplements decreases the progression of hepatic failure and improves the event-free survival and quality of life, as well as the serum albumin concentration, in patients with decompensated liver cirrhosis. In addition, diet with BCAA-enriched nutrient supplementation may prevent the aggravation of nutritional status in patients with liver cirrhosis during the treatment of portal hypertension.

Keywords

Protein-energy malnutrition (PEM) Hepatic encephalopathy Branched-chain amino acids (BCAA) Late evening snack (LES) Liver cirrhosis 

Notes

Acknowledgments

The authors would like to thank Dr. Akinobu Kato (Department of Gastroenterology, Morioka Municipal Hospital) and Dr. Kazuyuki Suzuki (Department of Nutritional Science, Morioka University), for their assistance in creating this article.

References

  1. 1.
    ASPEN Board of Disorders and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 2002;26(1 Suppl):65SA–8SA.Google Scholar
  2. 2.
    Plauth M, Cabré E, Riggio O, Assis-Camilo M, Pirlich M, Kondrup J, et al. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr. 2006;25:285–94.CrossRefGoogle Scholar
  3. 3.
    Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol. 2005;3:705–13.CrossRefGoogle Scholar
  4. 4.
    Schneeweiss B, Graninger W, Ferenci P, Eichinger S, Grimm G, Schneider B, et al. Energy metabolism in patients with acute and chronic liver disease. Hepatology. 1990;11:387–93.CrossRefGoogle Scholar
  5. 5.
    Müller MJ, Lautz HU, Plogmann B, Bürger M, Körber J, Schmidt FW. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology. 1992;15:782–94.CrossRefGoogle Scholar
  6. 6.
    Charlton MR. Energy and protein metabolism in alcoholic liver disease. Clin Liver Dis. 1998;2:781–98.CrossRefGoogle Scholar
  7. 7.
    Dolz C, Raurich JM, Ibáñez J, Obrador A, Marsé P, Gayá J. Ascites increases the resting energy expenditure in liver cirrhosis. Gastroenterology. 1991;100:738–44.CrossRefGoogle Scholar
  8. 8.
    Tajika M, Kato M, Mohri H, Miwa Y, Kato T, Ohnishi H, et al. Prognostic value of energy metabolism in patients with viral liver cirrhosis. Nutrition. 2002;18:229–34.CrossRefGoogle Scholar
  9. 9.
    Nishiguchi S, Habu D. Effect of oral supplementation with branched-chain amino acid granules in the early stage of cirrhosis. Hepatol Res. 2004;30S:36–41.CrossRefGoogle Scholar
  10. 10.
    Suzuki K, Endo R, Kohgo Y, Ohtake T, Ueno Y, Kato A, et al. Guidelines on nutritional management in Japanese patients with liver cirrhosis from the perspective of preventing hepatocellular carcinoma. Hepatol Res. 2012;42:621–6.  https://doi.org/10.1111/j.1872-034X.2012.00990.x.CrossRefPubMedGoogle Scholar
  11. 11.
    Plauth M, Cabré E, Campillo B, Kondrup J, Marchesini G, Schütz T, et al. ESPEN guidelines on parenteral nutrition: hepatology. Clin Nutr. 2009;28:436–44.  https://doi.org/10.1016/j.clnu.2009.04.019. Epub 2009 June.CrossRefPubMedGoogle Scholar
  12. 12.
    Fukui H, Saito H, Ueno Y, Uto H, Obara K, Sakaida I, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2015. J Gastroenterol. 2016;51:629–50.  https://doi.org/10.1007/s00535-016-1216-y. Epub 2016 May 31.CrossRefGoogle Scholar
  13. 13.
    Suzuki K, Kato A, Iwai M. Branched-chain amino acid treatment in patients with liver cirrhosis. Hepatol Res. 2004;30S:25–9.CrossRefGoogle Scholar
  14. 14.
    Nakaya Y, Okita K, Suzuki K, Moriwaki H, Kato A, Miwa Y, et al. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition. 2007;23:113–20.CrossRefGoogle Scholar
  15. 15.
    Kato A, Suzuki K. How to select BCAA preparations. Hepatol Res. 2004;30S:30–5.CrossRefGoogle Scholar
  16. 16.
    Suzuki K. Branched-chain amino acid supplementation during the endoscopic injection sclerotherapy for esophageal varices may be useful for maintenance of nutritional status in patients with liver cirrhosis. Hepatol Res. 2005;32:144–5.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Division of Medical Fundamentals for NursingIwate Medical UniversityShiwaJapan
  2. 2.Division of Hepatology, Department of Internal MedicineIwate Medical UniversityMoriokaJapan

Personalised recommendations